Antibodies New Wave of Alzheimer’s Research

Alzheimer's Research pic

Alzheimer’s Research
Image: sciencedaily.com

A seasoned recruiter and entrepreneur, Scott Robarge is the founder of Another8, a recruiting firm that primarily acquires talent for fast-paced technology companies. When he isn’t serving as a recruiter, Scott Robarge supports organizations that help lead the fight against Alzheimer’s disease.

Recent research efforts into the treatment of Alzheimer’s disease are focused on fighting the plaques that develop in the brain. Researchers believe that by understanding how to better manage these plaques, they may be able to delay its onset.

These plaques, which are a common sign of the condition, are tiny batches of beta-amyloid protein that deposit themselves in the brain and are responsible for brain cell degradation. Some antibodies, such as Aducanumab, have shown the propensity to reduce the amount of plaques that develop in Alzheimer’s patients, effectively slowing the rate of cognitive decline. It is thought that future research efforts in the battle against Alzheimer’s could include other combinations of medications in conjunction with these sorts of antibodies.

Advertisements